The website GuruFocus does a terrific job of parsing the portfolios of many of the most successful investors, mutual fund and hedge fund managers in the world. I love the site, because I like to see what the experts -- those successful investors -- are buying. I also like companies with high dividend yields. And to combine the two, I like to see dividend stocks that are being purchased by a lot more experts than are being sold.
I found seven companies with juicy dividends, which have all been purchased at a far greater rate during the last quarter than they have been sold. And these seven companies are all owned by more than 10 of the experts.
Top investors are buying these companies -- shouldn't you be considering them for your own portfolio?
The first company on the list is BP (BP). It is currently selling at approximately $43 per share, and is yielding 4.6%. While the company is still operating under the black cloud of the Gulf Oil Spill, it appears to be weathering the storm fairly well. The stock price is right in the middle between its 52-week high and low, and its one-year analyst target price provides a healthy 21% potential gain. The 13 analysts who cover the company rank it a 2.0 (1.0 = Strong Buy, 5.0 = Sell) with 4 Strong Buy ratings, 6 Buys and 3 Holds.
In terms of the experts who are tracked by Gurufocus, 21 currently own the stock. Fourteen experts bought into the company in the last quarter, and only one sold. Significant positions (over 1 million shares) are held by Richard Perry (Perry Capital), Seth Klaman (The Baupost Group), Richard Pzena (Pzena Investment Management), Charles Brandes (Brandes Investment), Brian Rogers (T Rowe Price Equity Income Fund), Bill Gates (Bill & Melinda Gates Foundation Trust) and James Barrow (Barrow, Hanley, Mewhinney & Strauss).
The second company is Vodafone Group (VOD). It is currently selling at approximately $28 per share, and is yielding 7.0%. The stock price is right in the middle of its 52-week range, and its target analyst price is 14% higher than current. The 5 analysts who cover the company currently rate it a 2.8 with 1 Buy and 4 Hold ratings.
Nineteen experts own this stock -- 7 bought into the company during the last quarter, and three sold. Significant positions are owned by James Barrow, Hotchkis & Wiley (mutual fund), Mason Hawkins (Southeastern Asset Management), Dodge & Cox (mutual fund), and Charles Brandes.
Avon Products (AVP) is the third high-yielding company on the list. It is currently selling at $17 per share, yielding 5.4%. Again, this stock is in the middle of its 52-week range, and its analyst target price offers only a 5% potential increase. The 17 analysts who cover the company currently rank it a 2.8, with 1 Strong Buy, 3 Buys, 11 Holds and 2 Underperforms.
Thirteen gurus currently own the company, with 11 buying in the last quarter and only 1 selling. Significant positions are held by Brian Rogers, Donald Yacktman (Yacktman Asset Management), and Richard Penza.
Excelon (EXC) is currently selling at $36 per share and yields 5.8%. The stock is up only 6% from its 52-week low, and sitting right at the analyst 1-year target price. The 19 analysts currently rate it a 2.5, with 2 Strong Buys, 4 Buys, and 13 Holds.
Eleven experts own the stock, with 7 buys and one sell in the last quarter. Significant positions are held by Hotchkis & Wiley, Brian Rogers and Donald Smith (Donald Smith & Co.).
Bristol Myers Squibb (BMY) is selling at $34 per share and yields 4.1%. The share price is in the middle of its 52-week range, and the analyst target price is only 50 cents above the current trading price. The 22 analysts who cover the company currently rate it a 2.5, with 5 Strong Buys, 4 Buys, 8 Holds, and 3 Underperforms.
Thirteen experts own the stock, with 7 buys and 3 sells in the previous quarter. Significant positions are held by Edward Owens (Vanguard Healthcare Fund), Brian Rogers, John Hussman (Hussman Econometrics Advisors), and James Barrow.
Total SA (TOT) is selling at $50 per share and yielding 5.0%. The share price is in the middle of its 52-week range, and the analyst target price offers 14% potential upside. Its 8 analysts rate it a 2.3, with 2 Strong Buys, 4 Buys, 1 Hold and 1 Underperform.
Twelve gurus own the company, with 8 purchases and 2 sales in the last quarter. Significant positions are held by Hotchkis & Wiley and Charles Brandes.
Old Republic International (ORI) is selling at $10 per share and yields 7.4%. It is trading at its 52-week high, and its analyst target price offers a hefty 70% potential gain. Its analysts rate the company a 2.8, with 3 Holds.
The company is owned by 10 investment experts, with 6 buying in the last quarter and 2 selling. Significant positions are held by Irving Kahn (Kahn Brothers) and Charles Brandes.